In-vitro and in-vivo antibiotic susceptibilities of Lyme disease borrelia isolated in China

Journal of Infection and Chemotherapy

Volumn 6, Issue 1, 2000, Pages 65-67

  Li, Muqing ^a   Masuzawa, Toshiyuki ^b   Wang, Jianhui ^b   Kawabata, Masato ^a   Yanagihara, Yasutake ^b  

^a KOBE UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Antibiotic susceptibilities; Borrelia burgdorferi; China; Lyme disease

Indexed keywords

AMOXICILLIN; ERYTHROMYCIN; MINOCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BORRELIA; BORRELIA BURGDORFERI; BORRELIA INFECTION; CHINA; CONTROLLED STUDY; DRUG ACTIVITY; IXODES PERSULCATUS; LYME DISEASE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN;

EID: 0034011608     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560050053     Document Type: Article

References (23)

1. Anderson JF. Epizootiology of Borrelia in Ixodes ticks; vectors and reservoir hosts. Rev Infect Dis 1989;11:S1451-9.
2. Jaenson TGT. The epidemiology of Lyme borreliosis. Parasitol Today 1991;7:39-45.
3. Duffy J. Lyme disease. Ann Allergy 1990;65:1-13.
4. Sigal LH. Current recommendations for the treatment of Lyme disease. Drugs 1992;43:683-99.
5. Steere AC, Grodzicki MS, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-40.
6. Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borne Borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann NY Acad Sci 1988;539:4-15.
7. Steere AC. Lyme disease. N Engl J Med 1989;321:586-96.
8. Agger WA, Callister SM, Jobe DA. In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone. Antimicrob Agents Chemother 1992;36:1788-90.
9. Berger BW, Johnson RC. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease. J Am Acad Dermatol 1989;21:1188-91.
10. Berger BW, Kaplan MH, Rothenberg IR, Barbour AG. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol 1985;13:444-9.
11. Dever LL, Jorgenson JH, Barbour AG. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol 1992;30: 2692-7.
12. Dever LL, Jorgenson JH, Barbour AG. In vitro activity of vancomycin against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother 1993;37:1115-21.
13. Johnson RC, Kodner C, Jurkovich PJ, Collins JJ. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents. Antimicrob Agents Chemother 1990;34:2133-6.
14. Johnson RC, Kodner C, Russell M. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother 1987;31: 164-7.
15. Preac-Mursic V, Wilske B, Scherz G, Holmburger M, Suss E. In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur J Clin Microbiol 1987;6:424-6.
16. Preac-Mursic V, Wilske B, Scherz G, Suss E, Gross B. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. Eur J Clin Microbiol 1989;8:651-3.
17. Preac-Mursic V. Antibiotic susceptibility of Borrelia burgdorferi in vitro and in vivo. In: Weber K, Burgdorfer W, editors. Aspects of Lyme borreliosis. Berlin Heidelberg Tokyo New York: Springer-Verlag; 1993. pp. 301-11.
18. Fujita H, Yamada K, Kurita T, Masuzawa T, Yanagihara Y. In vitro and in vivo antibiotic susceptibility of Lyme disease Borrelia isolated from the ixodid tick in Japan. J Dermatol 1995;22: 935-8.
19. Zhang ZF. Epidemiological features of Lyme disease in China. In: Yanagihara Y, Masuzawa T, editors. Proceedings of the international symposium on Lyme disease in Japan. Shizuoka: Hamamatsu; 1994. pp. 84-91.
20. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984;57:521-5.
21. Masuzawa T, Yamada K, Kawabata H, Yanagihara Y. In vitro antibiotic susceptibilities of Borrelia isolates from erythema migrans lesion of Lyme disease patients in Japan. Microbiol Immunol 1994;38:399-402.
22. Masuzawa T, Kurita T, Kawabata H, Suzuki H, Yanagihara Y. Experimental induction of Lyme arthritis in outbred mice. Microbiol Immunol 1994;38:263-8.
23. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-7.